These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35062749)

  • 21. Failure in dry period vaccination strategy for bovine viral diarrhea virus.
    Toker EB; Aytogu G; Kadiroglu B; Ates O; Yesilbag K
    Vet Microbiol; 2020 Aug; 247():108797. PubMed ID: 32768238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle.
    Pecora A; Aguirreburualde MS; Aguirreburualde A; Leunda MR; Odeon A; Chiavenna S; Bochoeyer D; Spitteler M; Filippi JL; Dus Santos MJ; Levy SM; Wigdorovitz A
    Vet Res Commun; 2012 Sep; 36(3):157-64. PubMed ID: 22639081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of cytopathic bovine viral diarrhea virus in the ovaries of cattle following immunization with a modified live bovine viral diarrhea virus vaccine.
    Grooms DL; Brock KV; Ward LA
    J Vet Diagn Invest; 1998 Apr; 10(2):130-4. PubMed ID: 9576338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Occurrence of a Commercial N
    Wernike K; Michelitsch A; Aebischer A; Schaarschmidt U; Konrath A; Nieper H; Sehl J; Teifke JP; Beer M
    Viruses; 2018 May; 10(5):. PubMed ID: 29783722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Diversity of Brazilian Bovine Pestiviruses Detected Between 1995 and 2014.
    Silveira S; Weber MN; Mósena AC; da Silva MS; Streck AF; Pescador CA; Flores EF; Weiblen R; Driemeier D; Ridpath JF; Canal CW
    Transbound Emerg Dis; 2017 Apr; 64(2):613-623. PubMed ID: 26415862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic diversity of Bovine Viral Diarrhea Virus from cattle in Chile between 2003 and 2007.
    Donoso A; Inostroza F; Celedón M; Pizarro-Lucero J
    BMC Vet Res; 2018 Oct; 14(1):314. PubMed ID: 30340596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of bovine viral diarrhea virus type 2 isolate originating from a native Indian sheep (Ovies aries).
    Mishra N; Rajukumar K; Vilcek S; Tiwari A; Satav JS; Dubey SC
    Vet Microbiol; 2008 Jul; 130(1-2):88-98. PubMed ID: 18308487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine.
    Zimmerman AD; Boots RE; Valli JL; Chase CC
    J Am Vet Med Assoc; 2006 Jun; 228(11):1757-61. PubMed ID: 16740078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
    Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
    Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of three inactivated bovine viral diarrhoea virus vaccines on bulk milk p80 (NS3) ELISA test results in dairy herds.
    Sayers RG; Sayers GP; Graham DA; Arkins S
    Vet J; 2015 Jul; 205(1):56-61. PubMed ID: 25986132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant E
    Wang S; Yang G; Nie J; Yang R; Du M; Su J; Wang J; Wang J; Zhu Y
    Vaccine; 2020 May; 38(22):3881-3891. PubMed ID: 32280039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea.
    Cortese VS; Whittaker R; Ellis J; Ridpath JF; Bolin SR
    Am J Vet Res; 1998 Jul; 59(7):848-50. PubMed ID: 9659549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of an Erns-based enzyme-linked immunosorbent assay to distinguish Classical swine fever virus-infected pigs from pigs vaccinated with CP7_E2alf.
    Pannhorst K; Fröhlich A; Staubach C; Meyer D; Blome S; Becher P
    J Vet Diagn Invest; 2015 Jul; 27(4):449-60. PubMed ID: 26179095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of long-term antibody responses to two inactivated bovine viral diarrhoea virus (BVDV) vaccines.
    González AM; Arnaiz I; Yus E; Eiras C; Sanjuán M; Diéguez FJ
    Vet J; 2014 Mar; 199(3):424-8. PubMed ID: 24461201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
    Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M
    Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.